History
A list of downloadable documents created during development.
Lymphoma (non Hodgkin's, relapsed, refractory) - pixantrone monotherapy: Equality Impact Assessment - guidance development
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: final appraisal determination 2
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation 2
-
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation 2
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation
-
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation
-
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: evaluation report
-
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: clarification
-
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: patient group, professional group and NHS organisation submission statements
-
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: expert written personal statements